BPA Call 75F40118A10047-75F40118F18001

Award Date 9/21/18
Potential Completion Date 9/23/24
Potential Value $23M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,646,482.02 firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business. The contract provides implementation support services for the HHS FDA's Unified Financial Management System (UFMS) modernization efforts. Services include transitioning systems to new platforms, integrating electronic invoicing, automating processes, and maintaining...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a Blanket Purchase Agreement (BPA) call to Equinoxys Inc., a Minority Owned, Small Disadvantaged Business, to provide invoice processing platform (IPP) support services for the FDA's Unified Financial Management System (UFMS). The firm fixed-price contract, valued at $596,386.44, has a period of performance through January 31, 2024. Equinoxys Inc. will deliver operations and maintenance, system...
The Department of Health and Human Services Food and Drug Administration awarded a $548,992.48 contract to Equinoxys Inc., doing business as Equinoxys Inc., to provide Unified Financial Management Systems (UFMS) Support Services. This contract was awarded under the Multiple Award Schedule contract vehicle and calls against the agency's master agreement with Equinoxys. Performance will take place in Calverton, Maryland over a one-year base period to support the FDA's financial management systems....
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a Minority-Owned, Self-Certified Small Disadvantaged Business, and Subcontinent Asian-American Owned IT services and management consulting company. The $2,640,656.71 contract calls for Equinoxys to provide architecture, implementation, and maintenance services for the FDA's Financial Management System (FMS) user fee re-architecture and electronic invoicing...
Equinoxys Inc., doing business as Equinoxys Inc., has been awarded a $93,802.72 firm-fixed-price blanket purchase agreement (BPA) call contract from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to provide KNIME and MongoDB licenses and associated support services. Performance will take place in Rockville, Maryland under the terms of the contractor's Multiple Award Schedule contract vehicle. The one-year BPA call, which runs from September 2023 through...
This is a $1,671,906.19 BPA Call contract awarded by the Food and Drug Administration (FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned company. The contract is to support the FDA's Unified Financial Management System (UFMS) and User Fee systems through IT modernization, data analytics, and professional services. Key efforts include transitioning legacy systems, unearned funds tracking, refund...
This is a Firm Fixed Price BPA Call order awarded by the Food and Drug Administration (FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned IT services company. The purpose of this $1,928,972.27 contract is to allow the FDA to continue collecting user fees from industry and report on these fee collections efficiently and accurately. The contract has an ultimate completion date of March 31, 2024 and is...
This is a delivery order contract awarded to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business, by the Food and Drug Administration (FDA) under the Multiple Award Schedule (MAS) contract vehicle. The contract, valued at $17,026,367.11, is for Operations and Maintenance (O&M) technical support services for the FDA's Unified Financial Management System (UFMS) and User Fee systems. The contract has a period of performance through March 23, 2026. Equinoxys Inc....
This is a $63,139.99 firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a minority-owned small disadvantaged business. The contract is a call under the General Services Administration (GSA) Multiple Award Schedule (MAS) to provide support for implementing modifications to the ADUFA and AGDUFA billing interfaces in the HHS FDA User Fee system. The objectives are to redesign and update the existing interfaces...
The U.S. Food and Drug Administration (FDA) awarded a contract to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business, for Unified Financial Management System (UFMS) cash management and accounting support services. The $1,296,382.52 Firm Fixed Price contract, awarded under the Information Technology Schedule 70 (IT-70) contract vehicle, has an ultimate completion date of September 23, 2023. Equinoxys Inc. is a key contractor for the FDA, providing a range of services to...

This is a $23,061,584.52 Blanket Purchase Agreement (BPA) call contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc. for Financial Management Systems (FMS) support services. The contract was awarded under the General Services Administration (GSA) Information Technology Schedule 70 contract vehicle and has a firm fixed price pricing structure. The contract supports FMS modernization efforts, including transitioning systems to new platforms, integrating electronic invoicing, automating processes, and maintaining infrastructure. Equinoxys Inc. has also provided analytical software, data management platforms, and IT infrastructure to support HHS FDA's regulatory oversight and public health mission. The contract has a performance period from September 21, 2018 to September 23, 2024 and did not use a small business set-aside.

Generated 3/22/24, 12:06 AM